Eldon C. Mayer III, EVP & Chief Commercial Officer at RIGEL PHARMACEUTICALS INC (RIGL), bought 100,000 shares at $3.23 ($326K) on 2018-09-11, disclosed to the SEC on 2018-09-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.28 | 50,000 | $164K | 50.4% |
| 2 | $3.23 | 50,000 | $162K | 49.6% |
| Total | $3.25 avg | 100,000 | $326K | 100% |
| Filing → |
| EIGR | SELL | 2022-01-11 | $8K | — | Filing → |
| EIGR | SELL | 2021-01-11 | $20K | — | Filing → |
| EIGR | BUY | 2020-01-30 | $68K | — | Filing → |